The Plasma Protein Therapeutics Association (PPTA) represents the private sector manufacturers of plasma-derived and recombinant analog therapies, collectively known as plasma protein therapies and the collectors of source plasma used for fractionation. These therapies are used by small patient populations worldwide to treat a variety of rare diseases and serious medical conditions.
PPTA works globally to:
PPTA Statement on the Documentary “Das Geschäft mit dem Blut” +
PPTA has viewed the documentary "Das Geschäft mit dem Blut" / "Le business du sang" (http://future.arte.tv/fr/le-business-du-sang) that will air on Feb. 21, 2017 in Germany, France, and Belgium on ARTE TV. PPTA strongly objects to the content of the documentary because it is not factual and contains numerous inaccuracies and misinformation.Read More
PPTA Remembers Corey Dubin +
The Plasma Protein Therapeutics Association (PPTA) notes with sadness the passing of Corey Dubin, President Emeritus of the Committee of Ten Thousand and longtime advocate in the hemophilia community.Read More
Registration open for the 2017 International Plasma Protein Congress! +